- call +1-201-465-4211
- email sales@mrinsights.biz
Market Overview
The global Companion Diagnostic Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Companion Diagnostic Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Companion Diagnostic Tests market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Companion Diagnostic Tests market has been segmented into:
Protein Detection
DNA Detection
Hybridization
Biomarker
Others
By Application, Companion Diagnostic Tests has been segmented into:
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Research Institutes
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Companion Diagnostic Tests market presented in the report. This section sheds light on the sales growth of different regional and country-level Companion Diagnostic Tests markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Companion Diagnostic Tests market.
The report offers in-depth assessment of the growth and other aspects of the Companion Diagnostic Tests market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Companion Diagnostic Tests Market Share Analysis
Companion Diagnostic Tests competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Companion Diagnostic Tests sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Companion Diagnostic Tests sales, revenue and market share for each player covered in this report.
The major players covered in Companion Diagnostic Tests are:
F. Hoffman LA Roche Ltd.
Siemens Healthcare GmBH
Agilent Technologies, Inc.
QIAGEN, Illumina, Inc.
AGENDIA NV
Abbott
BioMerieux SA, BioGenex
Genomic Health, Inc.
Thermo Fisher Scientific, Inc.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Companion Diagnostic Tests Market Overview
1.1 Product Overview and Scope of Companion Diagnostic Tests
1.2 Classification of Companion Diagnostic Tests by Type
1.2.1 Global Companion Diagnostic Tests Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Companion Diagnostic Tests Revenue Market Share by Type in 2019
1.2.3 Protein Detection
1.2.4 DNA Detection
1.2.5 Hybridization
1.2.6 Biomarker
1.2.7 Others
1.3 Global Companion Diagnostic Tests Market by Application
1.3.1 Overview: Global Companion Diagnostic Tests Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Medical Device Companies
1.3.4 Research Institutes
1.4 Global Companion Diagnostic Tests Market by Regions
1.4.1 Global Companion Diagnostic Tests Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Companion Diagnostic Tests (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Companion Diagnostic Tests Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Companion Diagnostic Tests Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Diagnostic Tests Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Companion Diagnostic Tests Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Diagnostic Tests Status and Prospect (2015-2025)
2 Company Profiles
2.1 F. Hoffman LA Roche Ltd.
2.1.1 F. Hoffman LA Roche Ltd. Details
2.1.2 F. Hoffman LA Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 F. Hoffman LA Roche Ltd. SWOT Analysis
2.1.4 F. Hoffman LA Roche Ltd. Product and Services
2.1.5 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.2 Siemens Healthcare GmBH
2.2.1 Siemens Healthcare GmBH Details
2.2.2 Siemens Healthcare GmBH Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Siemens Healthcare GmBH SWOT Analysis
2.2.4 Siemens Healthcare GmBH Product and Services
2.2.5 Siemens Healthcare GmBH Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.3 Agilent Technologies, Inc.
2.3.1 Agilent Technologies, Inc. Details
2.3.2 Agilent Technologies, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Agilent Technologies, Inc. SWOT Analysis
2.3.4 Agilent Technologies, Inc. Product and Services
2.3.5 Agilent Technologies, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.4 QIAGEN, Illumina, Inc.
2.4.1 QIAGEN, Illumina, Inc. Details
2.4.2 QIAGEN, Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 QIAGEN, Illumina, Inc. SWOT Analysis
2.4.4 QIAGEN, Illumina, Inc. Product and Services
2.4.5 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.5 AGENDIA NV
2.5.1 AGENDIA NV Details
2.5.2 AGENDIA NV Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AGENDIA NV SWOT Analysis
2.5.4 AGENDIA NV Product and Services
2.5.5 AGENDIA NV Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abbott SWOT Analysis
2.6.4 Abbott Product and Services
2.6.5 Abbott Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.7 BioMerieux SA, BioGenex
2.7.1 BioMerieux SA, BioGenex Details
2.7.2 BioMerieux SA, BioGenex Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 BioMerieux SA, BioGenex SWOT Analysis
2.7.4 BioMerieux SA, BioGenex Product and Services
2.7.5 BioMerieux SA, BioGenex Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genomic Health, Inc.
2.8.1 Genomic Health, Inc. Details
2.8.2 Genomic Health, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genomic Health, Inc. SWOT Analysis
2.8.4 Genomic Health, Inc. Product and Services
2.8.5 Genomic Health, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
2.9 Thermo Fisher Scientific, Inc.
2.9.1 Thermo Fisher Scientific, Inc. Details
2.9.2 Thermo Fisher Scientific, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Thermo Fisher Scientific, Inc. SWOT Analysis
2.9.4 Thermo Fisher Scientific, Inc. Product and Services
2.9.5 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Companion Diagnostic Tests Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Diagnostic Tests Players Market Share
3.2.2 Top 10 Companion Diagnostic Tests Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Companion Diagnostic Tests Revenue and Market Share by Regions
4.2 North America Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
4.3 Europe Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
4.5 South America Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
5 North America Companion Diagnostic Tests Revenue by Countries
5.1 North America Companion Diagnostic Tests Revenue by Countries (2015-2020)
5.2 USA Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
5.3 Canada Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
5.4 Mexico Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
6 Europe Companion Diagnostic Tests Revenue by Countries
6.1 Europe Companion Diagnostic Tests Revenue by Countries (2015-2020)
6.2 Germany Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
6.3 UK Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
6.4 France Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
6.5 Russia Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
6.6 Italy Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Companion Diagnostic Tests Revenue by Countries
7.1 Asia-Pacific Companion Diagnostic Tests Revenue by Countries (2015-2020)
7.2 China Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
7.3 Japan Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
7.4 Korea Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
7.5 India Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
8 South America Companion Diagnostic Tests Revenue by Countries
8.1 South America Companion Diagnostic Tests Revenue by Countries (2015-2020)
8.2 Brazil Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
8.3 Argentina Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Companion Diagnostic Tests by Countries
9.1 Middle East & Africa Companion Diagnostic Tests Revenue by Countries (2015-2020)
9.2 Saudi Arabia Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
9.3 UAE Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
9.4 Egypt Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
9.5 South Africa Companion Diagnostic Tests Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Companion Diagnostic Tests Revenue and Market Share by Type (2015-2020)
10.2 Global Companion Diagnostic Tests Market Forecast by Type (2019-2024)
10.3 Protein Detection Revenue Growth Rate (2015-2025)
10.4 DNA Detection Revenue Growth Rate (2015-2025)
10.5 Hybridization Revenue Growth Rate (2015-2025)
10.6 Biomarker Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Companion Diagnostic Tests Market Segment by Application
11.1 Global Companion Diagnostic Tests Revenue Market Share by Application (2015-2020)
11.2 Companion Diagnostic Tests Market Forecast by Application (2019-2024)
11.3 Pharmaceutical and Biotechnology Companies Revenue Growth (2015-2020)
11.4 Medical Device Companies Revenue Growth (2015-2020)
11.5 Research Institutes Revenue Growth (2015-2020)
12 Global Companion Diagnostic Tests Market Size Forecast (2021-2025)
12.1 Global Companion Diagnostic Tests Market Size Forecast (2021-2025)
12.2 Global Companion Diagnostic Tests Market Forecast by Regions (2021-2025)
12.3 North America Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
12.4 Europe Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
12.6 South America Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Companion Diagnostic Tests Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Companion Diagnostic Tests Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Companion Diagnostic Tests by Company Type (Tier 1, Tier 2 and Tier 3)
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
